Serum levels of anti-dsDNA autoantibodies
| Group . | Mice . | No. . | OD at 405 nm . |
|---|---|---|---|
| Control | BALB/c | 3 | 0.13 ± 0.035-150 |
| BXSB | 3 | 0.47 ± 0.05 | |
| BXSB→BXSB | 3 | 0.42 ± 0.065-151 | |
| Prevention | BALB/c→BXSB | 5 | 0.13 ± 0.03 |
| BALB/c+BXSB→BXSB | 5 | 0.25 ± 0.115-151 | |
| Transfer | BXSB→BALB/c | 5 | 0.28 ± 0.12 |
| BXSB+BALB/c→BALB/c | 5 | 0.25 ± 0.095-150 |
| Group . | Mice . | No. . | OD at 405 nm . |
|---|---|---|---|
| Control | BALB/c | 3 | 0.13 ± 0.035-150 |
| BXSB | 3 | 0.47 ± 0.05 | |
| BXSB→BXSB | 3 | 0.42 ± 0.065-151 | |
| Prevention | BALB/c→BXSB | 5 | 0.13 ± 0.03 |
| BALB/c+BXSB→BXSB | 5 | 0.25 ± 0.115-151 | |
| Transfer | BXSB→BALB/c | 5 | 0.28 ± 0.12 |
| BXSB+BALB/c→BALB/c | 5 | 0.25 ± 0.095-150 |
Serum levels of anti-dsDNA autoantibodies were examined by means of ELISA when recipients were 48 weeks old. The results are expressed as the mean ± SD of optimal density (OD).
P < .05 for BALB/c control mice versus BXSB+BALB/c→BALB/c transfer mice.
P < .05 for BXSB→BXSB control mice versus BALB/c+BXSB→BXSB treatment mice.